CANCELED - Lecture on Fibromyalgia and Migraines to Public April 7

**As of April 5, 2016, this event has been canceled**

The University of Cincinnati Neuroscience Institute and Department of Psychiatry and Behavioral Neuroscience present a lecture series on "Fibromyalgia and Migraines” from 6:30 – 8:30 p.m. Thursday, April 7, in Room 2108 of the Stetson building, 260 Stetson St. 

The program features the following speakers and presentations:

  • "Juvenile Fibromyalgia: What’s New?” by Tracy Ting, MD, assistant professor, UC Department of Pediatrics; Cincinnati Children’s Hospital Medical Center.

  • "Update on Migraine” by Vincent Martin, MD, professor of medicine and the director of the Headache and Facial Pain Program at the University of Cincinnati Neuroscience Institute, who has published extensive research on the topic of migraines.  Martin is the president of the Ohio Headache Association and vice president of the National Headache Foundation.

Presentation moderator will be Lesley Arnold, MD, professor in the Department of Psychiatry and Behavioral Neuroscience and director of the Women’s Health Research Program. Arnold has led numerous studies on the treatment of fibromyalgia. 

Lesley Arnold, MD

Lesley Arnold, MD

Tags

Related Stories

1

Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December

December 12, 2025

This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.

2

Ohio nurses weigh in on proposed federal loan rule

December 12, 2025

Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.

3

New combination treatment improves multiple myeloma outcomes

December 11, 2025

The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.